Brief: Exagen Inc Reports Q4 Revenue Of $12.8 Million
March 20 (Reuters) - Exagen Inc XGN.O :
* . REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS
* Q4 REVENUE $12.8 MILLION
* CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $62.4 MILLION
AS OF
DECEMBER 31, 2022
* QTRLY LOSS PER SHARE $0.83
* Q4 EARNINGS PER SHARE VIEW $-0.78 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX8xPqbj
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance